Cancer immunotherapy by adenosinergic CD39 and CD73 as emerging immune checkpoints
Crossref DOI link: https://doi.org/10.1007/s12672-025-04001-0
Published Online: 2025-11-24
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yin, Xinyu
Yang, Ying
Liu, Songjiang
Text and Data Mining valid from 2025-11-24
Version of Record valid from 2025-11-24
Article History
Received: 7 January 2025
Accepted: 31 October 2025
First Online: 24 November 2025
Declarations
:
: Not applicable.
: The authors declare no competing interests.